• Oncology
  • Exited

Potenza Therapeutics is a preclinical stage biotechnology company that is focused on cancer immunotherapy. Potenza is discovering and developing innovative therapeutics that stimulate a patients immune system to seek out and destroy cancerous cells. Potenza was founded by MPM Capital and leading researchers from Johns Hopkins University, Memorial Sloan Kettering Cancer Center, University of Pittsburgh, and Brigham and Women’s Hospital.